The science isn’t settled on 5G cell tower safety. American Cancer Society, WHO and American Academy of Pediatrics all agree we need more research first. The tower at Trinity Elementary currently sits less than 600ft away from the school but needs to be located a minimum of 1,640 feet away from children, their parks and their homes to minimize radiation on their developing bodies.

Right now we are relying on the tower owner, a third party company, Vogue Towers LLC., to choose the location and proximity to our children. We believe this should have been a decision made with feedback from the community and school after carefully reviewing health and safety concerns. We applaud and support Mayor Anderson’s efforts to work in tandem with Vogue towers to move this tower to a safer location. Our community will meet with the Mayor, our Commissioners, and Vogue Towers on Friday October, 27th 2023 to discuss safer locations but we need your support NOW.

Please take a moment TODAY to sign our petition below and/or email Mayor Anderson a quick note letting him know you support his efforts to move the tower a safe distance from the school.

Rogers.Anderson@williamsoncounty-tn.gov

Commissioners@williamsoncounty-tn.gov

Bill.jorgensen@williamsoncounty-tn.gov

Jasong@WCS.edu

Josh.Brown@WCS.edu

Dear _____,

I have just been made aware of the health and safety concerns regarding the cell tower at Trinity Elementary and respectfully request you assist in the relocation efforts to place the tower in a safer location nearby.

Thank you for your attention to this important matter, _________________

One of the most important things we can do is to come together as a community. Showing up in numbers at meetings will show the School Board and County that we truly care. Please join us to show your support. If you’d like to speak,  please prepare a 1-3 minute speech and arrive 15 minutes early. For meeting times and help with organizing subject matter please contact us via Facebook group linked above.

Thousands of peer-reviewed studies have documented the negative health effects associated with RF radiation exposure. More research is needed to clarify and dig deep into these findings. These problems include:

• Cancer
• Memory issues
• Irritability
• Blood issues
• Cardiovascular issues
• Sleep disorders
• Headaches
• Fatigue
• Ocular/visual disturbances
• Nausea

• Concentration/attention difficulties
• Skin disorders
• Tremors
• Anxiety
• Diabetes
• Reproductive ability/fertility
• Vertigo
• Tinnitus
• Verbal expression/comprehension
• Hair loss

AMERICAN CANCER SOCIETY:https://www.cancer.org/cancer/risk-prevention/radiation-exposure/cellular-phone-towers.html

AMERICAN ACADEMY OF PEDIATRICS: https://www.healthychildren.org/English/safety-prevention/all-around/Pages/Electromagnetic-Fields-A-Hazard-to-Your-Health.aspx?fbclid=IwAR3lDBV0esy2l7ukRBm8HTolPunJ_e8dKDP-hhBwwrUVkpKMlTRrVzeBPG4

Here is a list of some negative health effects reported to be caused caused by RF radiation exposure accompanied by peer reviewed, vetted scientific articles associating RF radiation with harm. There are many more available and we will be adding more as we move forward. You will notice there are NO long term studies on the effects of kids and 5G base stations at all.

Cancer:

Siddoo-Atwal, 2018; Khurana et al. (2010);  Gandhi et al. (2015);  Lopez et al. (2021);  Zothansiama et al. (2017); Levitt & Lai (2010);Dode et al. (2011); Pearce (2020);  Yakymenko et al. (2011);  Balmori (2022); Wold and Wolf (2004);  Eger et al. (2004); Li et al. (2012);  European Parliament (2021); Yakymenko et al. (2011)

Memory issues:

Balmori (2022); Santini et al. (2002); Shahbazi-Gahrouei et al. (2014); Abdel-Rassoul  et al. (2007);  Alba Cabré-Riera et al. (2021);Siddoo-Atwal (2018); Levitt & Lai (2010); Pearce (2020); Navarro et al. (2003);  Gulati et al. (2015);  Oberfeld et al. (2004);  Pall (2016); Bortkiewicz et al. (2012)

Depression:

Eger and Jahn (2010); Pall (2016); Santini et al. (2002);  Santini et al. (2003);  Shahbazi-Gahrouei et al. (2014);  Bortkiewicz  et al. (2004);  Siddoo-Atwal, 2018;  Silva et al. (2015); Levitt & Lai (2010);  Gulati et al. (2015);  Pall (2016); Oberfeld et al. (2004);  Abdel-Rassoul  et al. (2007); Pearce (2020);  Navarro et al. (2003)

Irritability:

Balmori (2022); Santini et al. (2002);  Shahbazi-Gahrouei et al. (2014);  Bortkiewicz  et al. (2004);  Singh et al. (2016);  Siddoo-Atwal, 2018;  Santini et al. (2003);  Navarro et al. (2003); Oberfeld et al. (2004);  Pall (2016); Gómez-Perretta et al. (2013)

Blood issues:

Eskander et al. (2012);  Gandhi et al. (2015); Hardell and Nilsson (2023); Zothansiama et al. (2017);  Gulati et al. (2015); Gandhi et al. (2017)

Cardiovascular issues:

Siddoo-Atwal, 2018;  Sharma & Lamba (2017);  Navarro et al. (2003); Singh et al. (2016)

Sleep disorders:

Balmori (2022); Kundi and Hutter (2009); Santini et al. (2002); Shahbazi-Gahrouei et al. (2014);  Abdel-Rassoul  et al. (2007);Bortkiewicz  et al. (2004);  Singh et al. (2016);  Siddoo-Atwal, 2018;  Hutter et al. (2006);  Sharma & Lamba (2017); Santini et al. (2003);  Lopez et al. (2021);  Levitt & Lai (2010); Pearce (2020); Navarro et al. (2003); Oberfeld et al. (2004);  Pall (2016); Gómez-Perretta et al. (2013)

Headaches:

Kundi and Hutter (2009); Santini et al. (2002); Shahbazi-Gahrouei et al. (2014); Abdel-Rassoul  et al. (2007); Bortkiewicz  et al. (2004); Singh et al. (2016);  Balmori (2022); Siddoo-Atwal, 2018; Hutter et al. (2006); Santini et al. (2003); Lopez et al. (2021);  Levitt & Lai (2010); Pearce (2020); Navarro et al. (2003);  Oberfeld et al. (2004); Pall (2016); Eger and Jahn (2010); Bortkiewicz et al. (2012);Parsaei et al. (2017);

Fatigue:

Balmori (2022); Siddoo-Atwal (2018);  Hardell and Nilsson (2023); Santini et al. (2003);  Pearce (2020); Navarro et al. (2003);Oberfeld et al. (2004); Pall (2016); Parsaei et al. (2017)

Ocular/visual disturbances:

Siddoo-Atwal, 2018;  Santini et al. (2003);  Navarro et al. (2003); Oberfeld et al. (2004); Durusoy et al. (2017);  Bortkiewicz  et al. (2004); Guxens et al. (2016)

Dizziness:

Balmori (2022); Santini et al. (2002); Shahbazi-Gahrouei et al. (2014); Abdel-Rassoul  et al. (2007); Singh et al. (2016);  Lopez et al. (2021);  Levitt & Lai (2010); Pearce (2020); Navarro et al. (2003); Oberfeld et al. (2004); Pall (2016); Eger and Jahn (2010); Parsaei et al. (2017)

Nausea:

Santini et al. (2002); Shahbazi-Gahrouei et al. (2014); Bortkiewicz  et al. (2004);  Santini et al. (2003); Navarro et al. (2003);Oberfeld et al. (2004); Pall (2016); Durusoy et al. (2017)

Concentration/attention difficulties:

Bortkiewicz  et al. (2004);  Singh et al. (2016);  Levitt & Lai (2010); Pearce (2020); Navarro et al. (2003); Oberfeld et al. (2004); Pall (2016); Gómez-Perretta et al. (2013); Durusoy et al. (2017); Balmori (2022); Kundi and Hutter (2009); Pall (2016); Ayoub Meo et al. (2018); Abdel-Rassoul  et al. (2007)

Libido issues:

Santini et al. (2002); Shahbazi-Gahrouei et al. (2014); Santini et al. (2003); Levitt & Lai (2010)

Skin disorders:

Hardell and Nilsson (2023); Levitt & Lai (2010); Pall (2016); Eger and Jahn (2010)

Tremors:

Levitt & Lai (2010); Durusoy et al. (2017); Pearce (2020); Kundi and Hutter (2009); Abdel-Rassoul  et al. (2007)

Anxiety:

Augner and Hacker (2009); Silva et al. (2015); Pall (2016)

Diabetes:

Ayoub Meo et al. (2015);  Eger and Jahn (2010)

Reproductive ability/fertility:

Al-Quzwini et al. (2016); European Parliament (2021)

Vertigo:

Parsaei et al. (2017);  Bortkiewicz  et al. (2004)

Tinnitus:

Hardell and Nilsson (2023)

Verbal expression/comprehension:

Calvente et al. (2016)

Hair loss:

Gulati et al. (2015)